Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kinesin family motor proteins (KIFs) constitute a large superfamily of ATP-dependent molecular motors that move unidirectionally along microtubule tracks to transport various cellular cargoes, including vesicles, organelles, and protein complexes [1.3.2, 1.3.5]. In humans, the superfamily consists of 45 members divided into 14-15 families, which are essential for fundamental processes such as intracellular trafficking, axonal transport in neurons, and the orchestration of mitosis and meiosis [1.1.3, 1.4.2]. During cell division, mitotic kinesins like KIF11 (Eg5) and CENP-E (KIF10) are critical for spindle assembly, pole separation, and accurate chromosome segregation [1.4.1, 1.4.4]. Due to their pivotal role in cell proliferation, several kinesins are frequently overexpressed in various cancers and have become significant therapeutic targets [1.2.2, 1.4.5]. Small-molecule inhibitors targeting the ATPase activity or allosteric sites of mitotic kinesins have been developed to induce mitotic arrest and apoptosis in tumor cells [1.1.1, 1.4.4]. Unlike traditional microtubule-targeting agents such as taxanes, kinesin inhibitors specifically target the motor proteins rather than the microtubules themselves, potentially offering a more selective therapeutic approach with a reduced risk of peripheral neurotoxicity [1.4.1]. Clinical development has primarily focused on KIF11 and CENP-E inhibitors, though challenges such as dose-limiting neutropenia remain a concern [1.4.2, 1.4.5].
Inhibition of ATPase activity, allosteric inhibition of the motor domain, disruption of microtubule binding, induction of mitotic arrest (monoastral spindles), and promotion of apoptosis [1.1.1, 1.4.4].
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin family motor proteins (KIFs) (KIFs).